In vitro radiosensitization of breast cancer with hypoxia‐activated prodrugs-Reference-Cited by-同舟云学术

In vitro radiosensitization of breast cancer with hypoxia‐activated prodrugs

Published:2022-07-16 Issue:16 Volume:26 Page:4577-4590
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cellular Molecular Medi

Author:

Aiyappa‐Maudsley Radhika¹²,Elsalem Lina³⁴,Ibrahim Ali I. M.³⁵,Pors Klaus³,Martin Stewart G.¹^ORCID

Affiliation:

1. Nottingham Breast Cancer Research Centre, Biodiscovery Institute, School of Medicine University of Nottingham, University Park Nottingham UK

2. Department of Molecular and Clinical Cancer Medicine University of Liverpool, William Henry Duncan Building Liverpool UK

3. Institute of Cancer Therapeutics, Faculty of Life Sciences University of Bradford Bradford UK

4. Jordan University of Science and Technology, Faculty of Medicine Department of Pharmacology Irbid Jordan

5. Faculty of Pharmacy Al‐Zaytoonah University of Jordan Amman Jordan

Funder

University of Nottingham

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.17486

Reference55 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. CRUK(2021)Breast Cancer Statistics.Accessed 15 October 2021http://www.cancerresearchuk.org/health‐professional/cancer‐statistics/statistics‐by‐cancer‐type/breast‐cancer.

3. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

4. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast

5. Role of hypoxia-inducible factors in breast cancer metastasis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cellular-centered view of hypoxia tumor microenvironment: Molecular mechanisms and therapeutic interventions;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Low serum albumin levels and high neutrophil counts are predictive of a poorer prognosis in patients with metastatic breast cancer;Oncology Letters;2022-10-19